Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.8500 (-5.19%) ($5.8500 - $5.8500) on Thu. Mar. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.66% (three month average) | RSI | 59 | Latest Price | $5.8500(-5.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.7% a day on average for past five trading days. | Weekly Trend | ANPC declines -2.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(17%) GLD(16%) VXX(14%) SLV(12%) GDX(10%) | Factors Impacting ANPC price | ANPC will decline at least -4.33% in a week (0% probabilities). ONLN(-14%) MCHI(-11%) XLY(-10%) FXI(-10%) VWO(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.33% (StdDev 8.66%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.68 | 5 Day Moving Average | $6.44(-9.16%) | 10 Day Moving Average | $6.7(-12.69%) | 20 Day Moving Average | $6.68(-12.43%) | To recent high | -30.9% | To recent low | 10.6% | Market Cap | $50m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |